Verona begins pilot study of potential COVID-19 inhaler
Inhaled ensifentrine will be assessed in hospitalised patients
Read More
Tag: inhaled
Gilead to start testing an inhaled form of remdesivir
The firm is targeting an earlier stage in the treatment pathway for COVID-19
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
